# NESINA
> **NDA022271** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2013-01-25
## Drug
- **FDA Application Number:** NDA022271
- **Application type:** New Drug Application
- **Brand name:** NESINA
- **Generic name:** ALOGLIPTIN
- **Active ingredients:** ALOGLIPTIN BENZOATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2013-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022271)
---
*MORVS · CC0 1.0*